SEC Form 4 · accession 0001104659-26-075124
Arqit Quantum Inc. · ARQQ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
d'Ovidio Manfredi Lefebvre
Director
Period of report
Jun 15, 2026
Accepted (ET)
Jun 17, 2026 · 4:05 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001859690
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Business Combination Warrants (right to buy)F1 | — | Jun 15, 2026 | S | 356 | D | — | Sep 3, 2026 | Ordinary Shares | 356 | 18,974 | I |
| Business Combination Warrants (right to buy)F1 | — | Jun 16, 2026 | S | 428 | D | — | Sep 3, 2026 | Ordinary Shares | 428 | 18,546 | I |
Explanation of responses
- F1On September 19, 2024, Arqit Quantum Inc. (ARQQ) announced the implementation of a reverse stock split whereby every 25 outstanding ARQQ ordinary shares were consolidated into one ordinary share, par value $0.0025 per share. Each Business Combination Warrant has an exercise price of $11.50 and can be exercised at any time, at the holder's election, to purchase 0.04 of an ARQQ ordinary share on a post-reverse stock split basis, and cannot be exercised for fractional shares. Accordingly, on a post-reverse stock split basis holders of Business Combination Warrants are required to exercise at least 25 Business Combination Warrants in order to receive one whole ARQQ ordinary share at an aggregate exercise price of $287.50 per whole ARQQ ordinary share. The reporting person beneficially owns 463,658 Business Combination Warrants, which, if exercised in full, would be equivalent to 18,546.32 ARQQ ordinary shares on a post-reverse stock split basis.
Remarks
Due to the issuer's status as a foreign private issuer pursuant to Rule 3a12-3(b) under the Securities Exchange Act of 1934 (the "Act"), the reporting person's transactions in the issuer's securities are exempt from Sections 16(b) and 16(c) of the Act.